Organization of activities for the prevention of increased antibiotic resistance in head and neck surgery hospitals


DOI: https://dx.doi.org/10.18565/epidem.2018.3.83-91

Daikhes N.A., Burkin A.V., Epifanova N.Yu.

Research and Clinical Center of Otorhinolaryngology, Federal Biomedical Agency of Russia, Moscow, Russia
Objective. To investigate the risk of increased antibiotic resistance to improve the quality of medical care, by rationalizing the use of antibiotics in head and neck surgery hospitals.
Materials and methods. The authors carried out a retrospective analysis of the consumption of antimicrobial drugs (AMDs) in a head and neck surgery during 2016 and investigated their consumption, by using the prospective audit strategy with an interventional component and feedback.
Results. Ceftriaxone is traditionally prescribed for the treatment of pyoinflammatory processes and perioperative antibiotic prophylaxis (PAP). The introduction of the prospective audit strategy has changed physicians’ stereotype in the prevention of PAP. The formation of a reserve of AMDs and transport nutrient media has ensured timely blood collection for bacteriological examination, as well as adequate antibiotic therapy just in the first hour after diagnosis at any time.
Conclusion. The prospective audit strategy with an interventional component and feedback contributes to the rational use of AMDs. The formation of a reserve of antibiotics and transport media can apply a de-escalation approach to treating severe infections and improving the quality of medical care.
Keywords: maxillofacial surgery, ceftriaxone, head and neck surgery, organization of medical care, ENT organs, antibiotic resistance, antibiotic prophylaxis
Read entire article

Literature

  1. Liu Y.-Y., Wang Y., Walsh T.R., Yi L.-X., Zhang R., Spencer J. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 2015; 16(2): 161–8. DOI: 10.1016/S1473-3099(15)00424-7. PMID: 26603172
  2. Review on Antimicrobial Resistance-Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, 2014. URL: https://ru.scribd.com/document/349597349/AMR-Review-Paper-Tackling-a-Crisis-for-the-Health-and-Wealth-of-Nations-1
  3. Renwick M.J., SimpkinV., Mossialos Е. Targeting innovation in antibiotic drug discovery and development (The need for a One Health–One Europe–One World Framework). World Health Organization, London, 2016. URL: http://www.euro.who.int/_data/assets/pdf_file/0003/315309/ Targeting-innovation-antibiotic-drug-d-and-d-2016
  4. Golub A.V., Kozlov R.S. [Rational antibacterial therapy – a way to preserve the activity of antibiotics]. Infektsionnyye Bolezni 2015; (1): 1–9. URL:https://docplayer.ru/31179616-Racionalnaya-antibakterialnaya-terapiya-put-k-sohraneniyu-aktivnosti-antibiotikov.html (In Russ.).
  5. Kozlov R.S. [Selection of Resistance Associated with the Use of Antimicrobial Agents: Collateral Damage Concept]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya 2010; 12(4): 284–94. URL: http://www.antibiotic.ru/cmac/pdf/cmac.2010.t12.n4.p284.pdf (In Russ.).
  6. Fridkin S.K., Edwards J.R., Courval J.M., Hill H., Tenover F.C., Lawton R. et al. The effect of vancomycin and trird-generation cefalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care unit. Ann. Intern Med. 2001; 135(3): 175–83. URL: https://www.ncbi.nlm.nih.gov/pubmed/11487484
  7. Landman D., Chokalingam M., Quale J. Reduction in the insidence of meticillin-resistant S. aureus and ceftazidim-resistant K. pneumoniae following changes in a hospital antibiotic formulary. Clin. Infect. Dis.1999; 28: 1062–6.
  8. Bisognano C., Vaudaux P., Rohner P., Lew D.P., Hooper D.C. Introduction of fibronectin-binding proteins and increased adhesion of quinolone-resistant S. aureus by subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 2000; 44: 1428–37.
  9. Tacconelli E., De Angelis G., Cataldo M.A., Pozzi E., Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J. Antimicrob. Chemother. 2008; 61: 26–38.
  10. Meyer E., Schwab F., Gastmeier P., Rueden H., Dasch­ner F.D., Jonas D. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). J. Hosp. Infect. 2006; 64: 238–43.
  11. Sukhorucova M.V., Edelstein M.V., Scleenova E.Yu., Ivanchik N.V., Micotina A.V., Dekhnich A.V., Kozlov R.S. [Antimicrobial resistance of nosocomial Enterobacteriaceae isolates in Russia: result of multicenter epidemiological study «MARATHON» 20013–2014]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya 2017; 19(1): 49–56. (In Russ.).
  12. Eydelshteyn M.V., Sukhorukova M.V., Skleyenova E.Yu., Ivanchik N.V., Mikotina A.V., Shek E.A., Dekhnich A.V., Azizov I.S., Kozlov R.S. [Antimicrobial resistance of nosocomial Pseudomonas aeruginosa isolates in Russia: result of multicenter epidemiological study MARATHON 20013–2014]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya 2017; 19(1): 37–41. (In Russ.).
  13. Sukhorucova M.V., Eydelshteyn M.V., Skleyenova E.Yu., Ivanchik N.V., Shek E.A., Dekhnich A.V., Azizov I.S., Kozlov R.S. [Antimicrobial resistance of nosocomial Acinetobacter spp. isolates in Russia: result of multicenter epidemiological study MARATHON 20013–2014]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya 2017; 19(1): 42–8. (In Russ.).
  14. Romanov A.V., Dekhnich A.V., Sukhorucova M.V., Skleyenova E.Yu., Ivanchik N.V., Eydelshteyn M.V., Kozlov R.S. [Antimicrobial resistance of nosocomial Staphylococcus aureus isolates in Russia: result of multicenter epidemiological study MARATHON 20013–2014]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya 2017; 19(1): 57–62. (In Russ.).
  15. Loomba P.S., Taneja J., Mishra B. Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients. J. Glob. Infect. Dis. 2010; 2 (3): 275–83.
  16. Petukhova I.N., Dmitrieva N.V., Grigorievskaya Z.V., Bagirova N.S., Tereshchenko I.V., Dyakova S.A. [Frequency of isolation of MRSA and other resistant gram-positive organisms in different departments of the oncology hospital]. Klinicheskaya laboratornaya diagnostika 2016; (9): 125–6. (In Russ.)
  17. Lubimova A.V, Shalyapina N.A., Eremin S.R. [Retrospective analysis of colonisation by vancomycin-resistant enterococci of patients of newborn intensive care unit]. Meditsinskiy almanakh 2014; 4(34): 35–8. (In Russ.)
  18. Aginova V.V., Dmitrieva N.V., Grigorievskaya Z.V., Petukhova I.N., Bagirova N.S., Tereshchenko I.V., Klyuchnikova I.A. [Rational approaches to the therapy of nosocomial infections caused by gram-positive microorganisms in cancer patients]. Sibirskiy onkologicheskiy zhurnal 2017; 16(5): 12–7. DOI: 10.21294/1814-4861-2017-16-5-12-17. (In Russ.).
  19. Krull M., Klare I., Ross B., Trenschel R., Beelen D.W., Todt D. et al. Emergence of linezolidand vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation. Antimicrob. Resist. Infect. Control. 2016; 22(5): 31.
  20. Dellit T.H., Owens R.C., McGowan J.E., Gerding D.N., Weinstein R.A., Burke J.P. et al. Infectious diseases society of America and the Society for healthcare epidemiology of America Guidelines for developing an Institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 2007; 44: 159–77. DOI: 10.1086/510393
  21. Aslanov B.I., Zueva L.P., Kolosovskaya E.N., Lyubimova A.V., Horoshilov V.Yu., Dolgij A.A., Darina M.G.. Tekhova I.G. [Principles of organization ofperioperative antibiotic prophylaxis in health care. Federal clinical recommendations]. Moscow, 2014. URL: http://nasci.ru/_resources/directory/198/ common/2014_9_PAP_new.pdf. (In Russ.)
  22. [The program SCAT (Strategy for Control of Antimicrobial Therapy) in the provision of inpatient care. Methodical recommendation]. Moscow, 2016. (In Russ.).
  23. Epifanova N.Yu., Kulabukhov V.V., Zhao A.V. [Principles of approach to antibiotic prophylaxis in surgery in modern conditions]. Vysokotekhnologicheskaya meditsina 2016; (1): 26–39. (In Russ.).
  24. Bratzler D.W., Dellinger E.P., Olsen K.M., Perl T.M., Auwaerter P.G., Bolon M.K. et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am. J. Health-Syst. Pharm. 2013; 70: 195–283. DOI: 10.2146/ajhp120568.
  25. Global Guidelines for the Prevention of Surgical Site Infection. World Health Organization. 2016: 1–184. http://www.who.int/gpsc/global-guidelines-web.pdf
  26. [Scat Program (Antimicrobial Therapy Control Strategy) in the Provision of Inpatient Care. Russian Clinical Guidelines]. Moscow, 2017. URL: http://www.antimicrob.net/upload/files/r_r_r_r_klinrekom_r_r_r_r_s_r_2_.pdf
  27. Gelfand B.R., ed. [Nosocomial pneumonia in adults. Russian national recommendations 2nd ed.]. Moscow: Meditsinskoye informatsionnoye agentstvo 2016. UPL: http://nasci.ru/_resources/directory/62/common/ NP.pdf (In Russ.).

For citations: Daikhes N.A., Burkin A.V., Epifanova N.Yu. Organization of activities for the prevention of increased antibiotic resistance in head and neck surgery hospitals. Èpidemiologiâ i infekcionnye bolezni. Аktual’nye voprosy 2018; (3):83–91


About the Autors

For correspondence:
Natalia Yu. Epifanova, MD. Clinical Pharmacologist, Research and Clinical Center of Otorhinolaryngology, Federal Biomedical Agency of Russia
Address: 30, Volokolamskoe Shosse, Build. 2, Moscow 123182, Russia
Telephone: +7(499) 968-69-04, extension number 21-14
E-mail: ne_nato2007@mail.ru
ORCID: http://orcid.org/0000-0001-8198-7131
Information about the authors:
Prof. Nikolai A. Daikhes, MD, Crresponding Member of the Russian Academy of Sciences, Director, Research and Clinical Center of Otorhinolaryngology, Federal Biomedical Agency of Russia, Moscow, Russia; e-mail: Otorhino1@yandex.ru; ОRCID: http://orcid.org/0000-0003-2674-4553
Prof. Aleksandr V. Burkin, MD, Deputy Medical Director, Research and Clinical Center of Otorhinolaryngology, Federal Biomedical Agency of Russia, Moscow, Russia; e-mail: burkin.1959@mail.ru


Similar Articles

Back to Content

Бионика Медиа